Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Vatanidipine

Catalog No. T24932Cas No. 116308-55-5
Alias AE-0047, AE0047, AE 0047

Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.A slow-onset and long-lasting hypotensive action was observed in various experimental hypertensive models.

Vatanidipine

Vatanidipine

Purity: 100%
Catalog No. T24932Alias AE-0047, AE0047, AE 0047Cas No. 116308-55-5
Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.A slow-onset and long-lasting hypotensive action was observed in various experimental hypertensive models.
Pack SizePriceAvailabilityQuantity
1 mg$197In Stock
5 mg$478In Stock
10 mg$654In Stock
25 mg$990In Stock
50 mg$1,330In Stock
100 mg$1,750In Stock
1 mL x 10 mM (in DMSO)$768In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Vatanidipine"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.A slow-onset and long-lasting hypotensive action was observed in various experimental hypertensive models.
In vivo
Vatanidipine (AE0047 ) (10 and 50 ng/kg/min) was administered intrarenally, increases in the basal renal blood flow and urine formation were observed. During Vatanidipine (50 ng/kg/min) infusion, low-frequency RNS-induced antidiuretic action and increase in NESR were markedly attenuated. In addition, high-frequency RNS-induced renal vasoconstriction was significantly suppressed by Vatanidipineinfusion at higher doses. Lower doses of Vatanidipine (10 ng/kg/min) tended to attenuate the low- and high-frequency RNS-induced antidiuretic actions, although neither of the RNS-induced increases in NESR were suppressed by lower doses of Vatanidipine[2].
AliasAE-0047, AE0047, AE 0047
Chemical Properties
Molecular Weight686.8
FormulaC41H42N4O6
Cas No.116308-55-5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 27.5 mg/mL (40.04 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.4560 mL7.2801 mL14.5603 mL72.8014 mL
5 mM0.2912 mL1.4560 mL2.9121 mL14.5603 mL
10 mM0.1456 mL0.7280 mL1.4560 mL7.2801 mL
20 mM0.0728 mL0.3640 mL0.7280 mL3.6401 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Vatanidipine | purchase Vatanidipine | Vatanidipine cost | order Vatanidipine | Vatanidipine chemical structure | Vatanidipine in vivo | Vatanidipine formula | Vatanidipine molecular weight